Trump Administration Threatens High Tariffs on Generic Drugs
Story essentials
Donald Trump, Apotex Inc., Canadian Generic Pharmaceutical Association
United States, Canada
July 21, 2026
This page is produced by collecting and structuring multiple public reports. Sections based only on reporting or testimony affect the displayed assessment, and the page is updated when new information is identified.
About this article
COMPAMIR Editorial Team
The COMPAMIR editorial team brings together public reporting and links to the original coverage. We update the page as new information emerges.
Read our editorial policy- Earlier version 17/22/2026, 7:41:11 PM
President Trump announced plans to impose 100% tariffs on generic drugs starting August 1, 2028, rising to 200% the following year. The policy aims to force the reshoring of pharmaceutical production to the United States. The move is expected to significantly impact Canada, which exports a large volume of generic drugs to the U.S.
Read next
Prioritized by shared people, places, and events.
Canada and U.S. Trade Talks Stalled Ahead of Retaliatory Tariffs
Canada and the U.S. have no plans to resume trade talks before Ottawa's retaliatory tariffs take effect on September 8. Canada's tariffs target $28 billion in U.S. goods, responding to previous U.S. levies. The Trump administration is considering further retaliatory measures, including potential bans on Canadian imports.